Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.

Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital, Australia.
AIDS (Impact Factor: 6.56). 11/2002; 16(15):2043-7. DOI: 10.1097/00002030-200210180-00009
Source: PubMed

ABSTRACT To further elucidate the immunopathogenesis of immune restoration diseases (IRD) in HIV patients responding to antiretroviral therapy and determine whether IRD associated with different opportunistic pathogens involve distinct immunopathological mechanisms.
DNA samples from patients with a range of IRD were typed for polymorphic loci in genes encoding immune-mediators.
PCR-restriction fragment length polymorphism assays were used to type loci in the and genes. Alleles of a microsatellite in the CD30 promoter were determined by capillary electrophoresis.
Only 8% of patients with IRD associated with a herpesvirus infection carried IL12B-3'UTR*2, compared with 42-54% of patients with other or no IRD. Patients with IRD arising from mycobacterial infection rarely carried IL6-174*C (36% versus 61-71%) and never carried TNFA-308*2 (0% versus 23-52%). TNFA-308*2 was carried by 52% of patients who experienced IRD associated with a herpesvirus infection, as several patients with exacerbations of cytomegalovirus retinitis carried this as part of a HLA-A2,B44 haplotype. Polymorphisms in and showed no distinct patterns.
Distinct cytokine-mediated mechanisms contribute to IRD initiated by herpesvirus and mycobacterial infections.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Wir stellen die Hypothese auf, dass sich ein ,,immune reconstitution inflammatory syndrome“ (IRIS) des Zentralnervensystems (ZNS) nach hochaktiver antiretroviraler Therapie (HAART) bei HIV1-positiven Patienten als schwere aseptische Leukenzephalopathie manifestieren kann und somit eine Steroidtherapie Erfolg versprechend ist.Wir zeigen eine Fallserie immunsupprimierter AIDS-Patienten, die nach HAART ein IRIS des ZNS entwickelten. Bei allen Patienten erfolgte eine ausgiebige infektiologische und radiologische Verlaufsdiagnostik, um Verlauf und zugrunde liegende Pathophysiologie zu verstehen. Eine Patientin starb und es erfolgte eine neuropathologische Aufarbeitung.Kein opportunistischer Erreger konnte vor oder während der hochaktiven antiretroviralen Therapie nachgewiesen werden. Drei der 4 Patienten konnten erfolgreich mit Methylprednisolon behandelt werden, wobei die HAART nie unterbrochen wurde. Die einzige afrikanische Patientin starb an einem Hirnödem.Unter HAART können HIV1-positive Patienten einen aseptischen Subtyp des IRIS entwickeln, der in vielen Fällen erfolgreich mit Kortikosteroiden behandelt werden kann. Dieser Subtyp ist bisher nicht publiziert worden. Möglicherweise hat IRIS bei Afrikanern eine höhere Inzidenz und zeigt ein schlechteres Outcome als bei Kaukasier.
    Der Nervenarzt 01/2009; 80(12). · 0.86 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tuberculosis-immune reconstitution inflammatory syndrome (TB-IRIS) is an exaggerated, dysregulated immune response against dead or viable antigens of Mycobacterium tuberculosis that frequently occurs after initiation of antiretroviral therapy despite an effective suppression of HIV viremia. Scientific advances in IRIS pathogenesis have led researchers and clinicians to postulate risk factors that could possibly predict this syndrome, in an attempt to reduce the incidence and the severity of IRIS, with appropriate anti-inflammatory therapy. This review is a summary of the available literature on pathogenic mechanisms involved from the macro to the micro level, the clinical spectrum, available predictors and the scope of these biomarkers to function as specific therapeutic targets, that could effectively modulate or ameliorate this syndrome in future.
    Expert Review of Clinical Immunology 03/2014; DOI:10.1586/1744666X.2014.892828 · 3.34 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Human Immunodeficiency Virus (HIV) and Schistosomiasis co-infection is common among residents at the shores of Lake Victoria in Kenya. About 36% of this population initiating antiretroviral therapy (ART) experience Immune Reconstitution Inflammatory Syndrome (IRIS) that complicates recovery. Several IL-23R alleles have been associated with susceptibility to both autoimmune and inflammatory diseases through T-helper type 17 (TH17) cells. However, whether or not variants within the IL-23R increase susceptibility to IRIS in western Kenya is unknown. The objective of the current study was to determine the association between IL-23R gene polymorphisms, CD4+ cell counts and HIV RNA levels and IRIS in HIV and Schistosoma mansoni co-infected patients undergoing highly active anti-retroviral therapy (HAART). Methods A three-month case–control study was conducted on antiretroviral naïve schistosomiasis/HIV co-infected fishermen starting HAART in Uyoma Rarieda, Siaya County, Kenya. Seventy one patients were sampled at baseline and followed up for three months, to establish if they developed Schistosoma-related IRIS. In addition, the CD4+ cell counts and HIV RNA levels were determined in pre- and post-administration of HAART. Variations at five polymorphic sites of IL-23R (rs1884444, rs11465754, rs6682925, rs7530511 and rs7539625) based on >10% minor allele frequency in Yoruban reference population was determined using Allelic Discrimination Assay. The association between the five variants and susceptibility to IRIS was determined using logistic regression while controlling for potential confounders. In addition, the functional differences between the baseline CD4 + Cell counts and viral loads were determined using medians while across IL-23R genotypes were determined using Kruskal-Wallis tests. Results Overall, 26 (36.6%) patients developed schistosomiasis-associated IRIS at a median age of 35.5 years. Carriage of the TT genotype at the non-synonymous rs1884444 T > G relative to GG, was associated with a decreased risk of schistosomiasis-associated IRIS (OR, 0.25, 95% CI, 0.07-0.96, P = 0.043) while both baseline CD4+ cell counts and viral loads had no association with IRIS. Conclusion These findings indicate that the non-synonymous variant rs1884444 T > G of IL-23R is associated with a decreased risk to schistosomiasis-associated IRIS. However, additional studies in a larger cohort and with an all inclusive polymorphic variants in the synonymous and non-synonymous regions need to be evaluated.
    BMC Infectious Diseases 06/2014; 14(1):316. DOI:10.1186/1471-2334-14-316 · 2.56 Impact Factor